“Equine Releaf” debuted by Pet Releaf
Pet Releaf, the market-leading CBD hemp health brand for pets, today debuted its new line of products developed specifically for horses.
Pet Releaf’s first two products contain a special formulation chosen for its beneficial properties:
Equine Oral Syringe 300 is comparable to tinctures for dogs and cats. It was designed with livestock specifically in mind and comes in an oral syringe for easy administration to horses and other large animals. Each syringe has a palatable apple flavor and contains 30, 10 mg units of active CBD for a total of 300 mg active CBD per container.
Equine Salve 150 is the go-to product for scrapes and cuts, which is common with livestock. Each container includes colloidal silver to aid the body in fighting infection, olive oil to reduce inflammation, Cajeput essential oil to fight off bugs and insects. It contains 150 mg of active CBD per container. All of these ingredients provide the perfect blend to aid the body with recovery.https://www.businesswire.com/news/home/20200227005272/en/Pet-Releaf-Debuts-Equine-Releaf%E2%84%A2-CBD-Product
Rapid Funders assists companies like Pet Releaf with working capital loans to help rapidly grow their businesses.